CEO Bayer Pharma AG,
“It’s all or nothing.”
Bayer HealthCare Pharmaceuticals has set itself an ambitious goal: we want to improve people's health and quality of life with innovative therapies. This is the basis of our current and future economic success. However, economic strength also means a great responsibility. We would like all people to share the fruits of medical progress, regardless of their origins or income. We support programs that provide access to innovative medicines and modern family planning, and take up the fight against neglected diseases. We work side-by-side with aid agencies, international bodies and policy makers.
As a company, we are firmly rooted in society – as a reliable employer and trainer, as a good neighbor at our locations all over the world, as an organization that uses and protects natural resources. It comes natural to us to deal with people and nature in a respectful and sustainable manner, to act unconditionally in accordance with applicable laws, and to maintain the highest standards.
We believe responsibility lays the foundation for long-term confidence in the reliable, high quality of our work and products. There must be a healthy balance between economy, ecology and society – and this conviction is the basis of our actions.
According to the annual report of the German Foundation for World Population, 76 million women unintentionally become pregnant worldwide every year. More than half a million women die from complications during pregnancy or at birth. And unplanned children increase the risk of poverty.
Enabling self-determined family planning at affordable prices and reducing maternal and infant mortality are key objectives of our engagement.
In developing and emerging countries, it is the poorest of the poor who are worst affected by diseases. Contaminated drinking water and a lack of sewage systems accelerate the spread of tropical and infectious diseases.
There is an urgent need for action, especially against what are known as neglected tropical diseases. About a billion people are affected worldwide. We support the WHO in its fight against Chagas disease, malaria and African sleeping sickness. Furthermore, together with the Global Alliance for TB Drug Development, we are searching for an improved treatment for tuberculosis.
Millions of people are excluded from basic healthcare – not only in developing countries. In industrialized countries, too, there are many people who cannot afford vital but costly therapies. We are committed to enabling people – not only in developing countries – to access important drugs and in this way to improving healthcare standards.